International Pharmaceutical Regulatory Monitor
August 2012
| Vol.
40 No.
8
Value-Based Pricing: UK Set to Begin Negotiations on New Brand Drugs Scheme
Negotiations on the future of UK pricing and reimbursement policies for brand drugs will begin in September, according to a joint statement by the Department of Health and the Association of the British Pharmaceutical Industry (ABPI).
This article is viewable by subscribers only. To view this article, please select an option below.
|